Newborn Screening for Sickle Cell Disease

In Pennsylvania, a newborn screening for hemoglobinopathies (abnormalities of hemoglobin), such as sickle cell disease and thalassemia, began formally in September 1992. Newborns diagnosed with an abnormality are referred to three treatment centers: Children’s Hospital of Pittsburgh of UPMC, Children’s Hospital of Philadelphia and St. Christopher’s of Philadelphia.

Information for Parents

Did your baby’s newborn screening indicate a hemoglobin trait? If so, this video explains what the results mean and what to do next.

Information for Health Care Providers

Newborn Screening Presentation

View a presentation that provides information about newborn screening and its implications for sickle cell disease and sickle cell trait.

For more information about newborn screening for hemoglobinopathies visit, www.neogenscreening.com

Top

Updated 7/23/07